M F Gonzales

RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.

P Corvol, A Yiotakis, V Dive, 2001, The Journal of pharmacology and experimental therapeutics.